Some Melanoma Survivors Still Seek Out the Sun
By webmd.com
Even after surviving the potentially deadly skin cancer melanoma, some people continue to go out in the summer sun without protection.
That's the stunning finding of a study of more than 700 melanoma survivors that revealed that 20 percent of them had suffered a sunburn in the past year. And only 62 percent said they "often" or "always" wore sunscreen when they were outside on a summer day.
But many melanoma survivors are more vigilant about sun protection than other people their age, the study also found.
"They're doing OK, but there's room for improvement," said study lead researcher Rachel Vogel. She's an assistant professor at the University of Minnesota's department of obstetrics, gynecology and women's health.
Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society (ACS), agreed.
"Survivors are doing better than other people, but that's not good enough," said Lichtenfeld, who was not involved in the study.
Until now, little has been known about sun exposure among melanoma survivors. So the new findings offer "important information" to doctors caring for those patients, he added.
"There can be an assumption among health care providers that patients are following our advice," Lichtenfeld noted. "But we can't assume."
The findings were published March 2 in the journal Cancer Epidemiology, Biomarkers & Prevention.
Melanoma is the least common -- but most dangerous -- form of skin cancer. The ACS estimates that roughly 87,000 Americans will be diagnosed with melanoma this year, and nearly 10,000 will die of the disease.
While melanoma accounts for only 1 percent of all skin cancers in the United States, it is responsible for most deaths.
What's more, melanoma has been on the rise for the past 30 years, according to the ACS. There are probably multiple reasons for that, Vogel said, but people's greater exposure to ultraviolet light from the sun is thought to be one.
In general, doctors say, the most important step people can take to cut their melanoma risk is to limit their exposure to ultraviolet (UV) light -- from the sun or tanning beds.
And that advice certainly applies to melanoma survivors, to lower the chances of a recurrence, Lichtenfeld said.
"We do know that additional UV exposure adds to the risk. It's cumulative," he explained.
The new findings were based on a survey of 724 melanoma survivors and 660 adults the same age with no history of the disease (the "control" group). On average, the survivors had been diagnosed 10 years earlier, when they were between the ages of 25 and 59.
The good news, the study found, was that most survivors were more vigilant about sun protection compared to the control group.
But there was not-so-good news, too. Three-quarters of survivors, for instance, said they typically spent at least two hours in the summer sun on weekend days.
And that was often without optimal protection. Roughly 38 percent said they usually did not wear sunscreen when they were outside in the summer. And less than half said they typically tried to stay in the shade, the findings showed.
Overall, 20 percent of survivors said they'd had a sunburn in the past year. And 10 percent said they'd sunbathed with the aim of getting a tan.
What the study cannot answer is why.
But Vogel speculated on some reasons.
The passage of time could be one, she said: Other research suggests that melanoma survivors are fairly vigilant about sun protection soon after their diagnosis -- but that wanes over time.
It's also possible that some survivors do not understand how serious melanoma is, Vogel said. Unless they are fully educated about the disease, they might not realize it's different from the much more common, less aggressive forms of skin cancer.
Plus, Vogel said, "behavior change, in general, is difficult."
Lichtenfeld agreed. While staying out of the sun might sound easy, he noted, that's not always true.
Some people have jobs, or active lifestyles, that keep them outside, Lichtenfeld said. And they may not always remember to cover up or slather on sunscreen.
And, he added, "There is research showing that for some people, tanning can be addictive."
To Vogel, the findings have a clear practical implication: "Doctors and patients should talk about making sun protection routine," she said. "Make it a part of your daily life to use sunscreen, wear long sleeves and put a hat on."
But, that advice isn't only for melanoma survivors, Vogel said. It can also help protect people from developing the cancer in the first place, she said.
Source: http://www.webmd.com/melanoma-skin-cancer/news/20170302/some-melanoma-survivors-still-seek-out-the-sun
Monday, May 11, 2026
Recognizing Vaginal Yeast Infection Patterns Requiring Antifungal Treatment Evaluation
Vaginal yeast infections present with distinctive itching, discharge changes, and discomfort that distinguish them from bacterial infections requiring different treatment approaches. Early recognition enables appropriate treatment selection. Vaginal yeast infections typically develop gradually over days as Candida populations expand in responsive vaginal environment. Some women experience sudden onset while others report gradual symptom development. Recognizing progressive itching and discharge changes enables prompt treatment initiation supporting faster symptom resolution and comfort restoration. Vaginal discharge changes characteristically accompany yeast infection creating distinctive appearance. Discharge becomes thick, white, cottage cheese textured or curd-like in consistency. This distinctive discharge appearance with odorless quality helps distinguish yeast from bacterial infections requiring different treatment medications. Vulvar swelling and redness accompany yeast infection creating visible inflammation. The area becomes tender and irritated. Burning sensation during urination or intercourse develops from inflamed sensitive tissue. Yeast infection occurs most commonly in reproductive years of women though older women sometimes develop infections after menopause. Pregnancy increases yeast infection risk through immune system changes and physiologic factors. Risk factors for yeast infection include prolonged antibiotic use disrupting normal flora, poorly controlled diabetes, oral contraceptive use affecting vaginal chemistry, and immune system compromise. Understanding personal risk factors helps recognize when symptoms likely represent yeast infection versus other conditions requiring different treatment approaches. Recurrent yeast infections occurring more frequently than four episodes yearly suggest chronic candida colonization or significant predisposing factors. Recurrent infections warrant professional investigation to identify underlying causes including diabetes control or immune system problems. Learn about miconazole treatment for yeast infection during healthcare evaluation. Understanding medication options helps prepare for clinical visit and treatment discussions. Male partners sometimes develop penile yeast infection from sex with infected women. Partner treatment prevents reinfection cycle through sexual transmission. Discussing partner symptoms with healthcare provider ensures appropriate treatment. Non-infectious vulvovaginitis from irritant or allergic reactions creates similar symptoms to yeast infection. Professional evaluation distinguishes yeast from other causes. Unnecessary yeast treatment occurs if diagnosis isn't confirmed through evaluation. Vaginal cultures or microscopy confirm yeast infection diagnosis when clinical presentation remains unclear. Candida identification confirms organism type and guides medication selection appropriately. For comprehensive information on vaginal yeast infection evaluation and evidence based antifungal treatment decisions, explore professional approaches to vaginal yeast infection management. Professional evaluation enables appropriate treatment selection supporting prompt symptom resolution and complete infection clearance.
Thursday, May 7, 2026
Sertraline: The Generic Form Of Zoloft Explained
Sertraline is the generic name of the medication sold under the brand name Zoloft. Generic medications contain the same active ingredient at the same dose and strength as their brand name counterparts and must meet the same FDA standards for quality, purity, and bioequivalence. The development and approval of generic drugs play an important role in making effective treatments more accessible and affordable for patients. Antidepressant medications have been central to depression treatment for decades. The first antidepressants developed, the monoamine oxidase inhibitors and tricyclic antidepressants, were effective but had significant side effect profiles that limited their use. The introduction of selective serotonin reuptake inhibitors in the 1980s represented a major advance, offering comparable efficacy with substantially improved tolerability. Today there are multiple antidepressant classes available, allowing treatment to be tailored to the individual patient's needs and tolerability. The pharmacological action of sertraline is the basis for its use in treating conditions within the category of antidepressant medications. Understanding the mechanism by which the active compound produces its therapeutic effects helps patients appreciate why the medication needs to be taken consistently and at the correct dose to achieve the best results. Switching between brand name and generic versions of a medication is generally considered safe when the products are bioequivalent, but patients should inform their doctor if they notice any differences in effect after a formulary change. Some patients with conditions requiring precise drug levels in the blood may be monitored more closely during transitions. For most patients, however, approved generics provide equivalent therapeutic benefit to the brand name product. The antidepressant medications section on antidepressant medications covers both brand name and generic treatment options, giving patients a complete picture of what is available. Cost, insurance coverage, and pharmacy availability are practical factors to discuss with a pharmacist when filling a prescription for sertraline.
Subscribe to:
Posts (Atom)